(2E)-2-[2-(4-Methylphenyl)hydrazin-1-ylidene]-3-oxo-3-(pyridin-4-yl)propanal

Catalog No. :
ACSDSJ699
CAS No. :
338414-03-2
Molecular Formula :
C15H13N3O2
Molecular Weight :
267.29

IUPAC Name:(E)-3-oxo-3-(pyridin-4-yl)-2-(2-(p-tolyl)hydrazineylidene)propanal

(2E)-2-[2-(4-Methylphenyl)hydrazin-1-ylidene]-3-oxo-3-(pyridin-4-yl)propanal structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$567.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E)-2-[2-(4-Methylphenyl)hydrazin-1-ylidene]-3-oxo-3-(pyridin-4-yl)propanal
IUPAC Name(E)-3-oxo-3-(pyridin-4-yl)-2-(2-(p-tolyl)hydrazineylidene)propanal
MDL No.MFCD00975104
Molecular FormulaC15H13N3O2
Molecular Weight267.29
SMILESCC1=CC=C(N/N=C(\C=O)C(=O)C2=CC=NC=C2)C=C1
InChI KeyJSSCFAOMJYSWJY-NBVRZTHBSA-N
Synonym2-[2-(4-METHYLPHENYL)HYDRAZONO]-3-OXO-3-(4-PYRIDINYL)PROPANAL;(2E)-2-[2-(4-methylphenyl)hydrazin-1-ylidene]-3-oxo-3-(pyridin-4-yl)propanal;(2E)-3-hydroxy-1-(pyridin-4-yl)-2-(p-tolyldiazenyl)prop-2-en-1-one;4-Pyridinepropanal, α-[2-(4-methylphenyl)hydrazinylidene]-β-oxo-
CAS No.338414-03-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSDSJ699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSDSJ699 route product structure diagram
    ACSDSJ699338414-03-2
Inquiry

2. ACSDSJ699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSDSJ699 route product structure diagram
    ACSDSJ699338414-03-2
Inquiry

Comments (0)